Risperidone versus other atypical antipsychotic medication for schizophrenia.

Gilbody SM, Bagnall AM, Duggan L, Tuunainen A

DOI: 10.1002/14651858.cd002306
Published: 2000
Container: The Cochrane database of systematic reviews
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/14651858.cd002306,
  title = {Risperidone versus other atypical antipsychotic medication for schizophrenia.},
  author = {Gilbody SM and Bagnall AM and Duggan L and Tuunainen A},
  year = {2000},
  journal = {The Cochrane database of systematic reviews},
  doi = {10.1002/14651858.cd002306},
  url = {https://doi.org/10.1002/14651858.cd002306}
}

RIS

TY  - JOUR
TI  - Risperidone versus other atypical antipsychotic medication for schizophrenia.
AU  - Gilbody SM
AU  - Bagnall AM
AU  - Duggan L
AU  - Tuunainen A
PY  - 2000
JO  - The Cochrane database of systematic reviews
DO  - 10.1002/14651858.cd002306
UR  - https://doi.org/10.1002/14651858.cd002306
ER  -

APA

SM, G., AM, B., L, D., & A, T. (2000). Risperidone versus other atypical antipsychotic medication for schizophrenia.. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd002306

Source records

pubmed · retrieved 2026-11-10T10:32:57.773Z